ModerateSynergy
Folic acid supplementation is standard of care during methotrexate therapy. Methotrexate is a folate antagonist that depletes intracellular folate, causing side effects including mucositis, nausea, and cytopenias. Folate supplementation significantly reduces these adverse effects without compromising methotrexate efficacy for rheumatologic conditions.
Recommendation: Take folic acid 1mg daily (or folinic acid 5mg weekly, 24 hours after MTX dose) during methotrexate therapy. This is guideline-recommended and reduces GI, hepatic, and hematologic toxicity. Discuss timing with your rheumatologist.
InfoSynergy
Fish oil (EPA/DHA) may have additive anti-inflammatory effects when combined with methotrexate for rheumatic conditions. Some studies suggest that omega-3 supplementation may allow reduced NSAID use in patients on MTX, improving overall tolerability of the treatment regimen.
Recommendation: Fish oil supplementation (2-3g EPA+DHA/day) may be a beneficial adjunct to methotrexate therapy for inflammatory conditions. No timing separation is needed. Discuss with your rheumatologist.
SeriousConflict
St. John's Wort induces CYP enzymes and P-glycoprotein that may affect methotrexate metabolism and transport. While methotrexate is primarily renally cleared, changes in hepatic metabolism and P-gp-mediated transport can alter drug levels and potentially reduce efficacy or increase toxicity.
Recommendation: Avoid St. John's Wort while on methotrexate. The potential for unpredictable changes in drug levels and the serious consequences of both subtherapeutic and supratherapeutic MTX levels make this combination inadvisable.
SeriousCaution
NSAIDs reduce renal clearance of methotrexate, potentially leading to toxic methotrexate accumulation. This can cause severe bone marrow suppression, hepatotoxicity, and nephrotoxicity.
Recommendation: Avoid concurrent use, especially with high-dose methotrexate. If low-dose methotrexate (for RA) is combined with occasional NSAID use, monitor CBC and renal function closely.
SeriousCaution
Naproxen, like other NSAIDs, reduces renal clearance of methotrexate. The longer half-life of naproxen may pose even greater accumulation risk compared to short-acting NSAIDs.
Recommendation: Avoid concurrent use with high-dose methotrexate. Use with extreme caution alongside low-dose methotrexate. Monitor renal function and CBC regularly.
SeriousCaution
Alcohol can add to methotrexate's liver toxicity risk, especially with regular or heavy use. The risk is most important for people with rheumatoid arthritis taking long-term low-dose methotrexate, people with abnormal liver tests, obesity, fatty liver disease, viral hepatitis, or other hepatotoxic medicines. Occasional low intake may be lower risk, but repeated intake makes liver enzyme monitoring more important.
Recommendation: Avoid heavy drinking while taking methotrexate. If you drink alcohol at all, keep intake low and consistent, tell your prescriber, and do not skip scheduled liver blood tests. Stop alcohol and seek medical advice if you develop jaundice, dark urine, unusual fatigue, or right upper abdominal pain.
ModerateSynergy
Vitamin B9 supplementation reduces common methotrexate side effects such as mouth sores, nausea, elevated liver enzymes, and blood-count problems in rheumatologic use. Methotrexate is an antifolate drug, so folate support is often part of safe long-term therapy. The benefit applies to low-dose weekly methotrexate regimens, not high-dose oncology protocols unless the oncology team directs it.
Recommendation: Use Vitamin B9 only in the schedule your prescriber recommends, commonly daily folic acid or a weekly folate dose away from methotrexate. Do not use folate to self-treat severe mouth sores, fever, bruising, or shortness of breath; those symptoms need urgent clinical review. Keep routine blood-count and liver-test monitoring.
NutriStack